Immunology
2 drugs are in development for Asthma.
- Companies
- 1
- Clinical trials
- 91
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Asthma pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| APG777 | Apogee Therapeutics, Inc. (APGE) |
Phase 1(1)
| Drug | Company |
|---|---|
| APG808 | Apogee Therapeutics, Inc. (APGE) |
About this indication
Asthma context
Immunology·MeSH: Asthma (D001249)
Also known as: Asthma, Bronchial, Asthmas
Prevalence
8000.0 / 100K
Incidence
400.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Asthma?
BioSniper tracks 2 drugs in development for Asthma across 1 company.
How many clinical trials target Asthma?
There are 91 clinical trials targeting Asthma tracked by BioSniper.
What is the prevalence of Asthma?
The estimated prevalence of Asthma is approximately 8000.0 per 100,000 population.